[1]
2022. Safety of Favipiravir for Treatment of COVID-19: Latest Systematic Review. Jurnal Respirologi Indonesia. 42, 1 (Feb. 2022), 67–75. DOI:https://doi.org/10.36497/jri.v42i1.243.